All AbMole products are for research use only, cannot be used for human consumption.
BIBR1532 is a potent and selective telomerase inhibitor with IC50 of 100 nM. BIBR 1532 inhibits the proliferation of JVM13 leukemia cells with an IC50 of 52 μM, and similar effect also occurs in other leukemia cell lines such as Nalm-1, HL-60, and Jurkat. The selectivity of BIBR1532 was assessed in a panel of DNA and RNA polymerases, including HIV reverse transcriptase, showing that none of these enzymes was inhibited at concentrations vastly exceeding the IC50 for telomerase.
BIBR1532 is also an inhibitor of TERT, the rate-limiting enzyme in the regulation of telomerase activity.
 |
Source | Target Oncol (2015). Figure 3. BIBR1532 |
| Method | cell apoptosis assay | |
| Cell Lines | MCF-7 cells | |
| Concentrations | 10 μM | |
| Incubation Time | 24 h | |
| Results | The drug combination induced 28.67±2.03 % apoptosis, which is significantly higher than apoptosis caused by 20 μM BIBR1532 alone. |
 |
Source | Target Oncol (2015). Figure 2. BIBR1532 |
| Method | colony formation assay | |
| Cell Lines | MCF-7 cells | |
| Concentrations | 10 μM | |
| Incubation Time | 72 h | |
| Results | BIBR1532 and paclitaxel alone inhibited cell colony formation in a dose-dependent manner in MCF-7 cells. |
| Cell Experiment | |
|---|---|
| Cell lines | JVM13 cells |
| Preparation method | Telomerase activity measurements. Telomerase activity of cell populations was determined using the TeloTaGGG polymerase chain reaction enzyme-linked immunosorbent assay (PCR ELISAPLUS) kit (Roche, Mannheim, Germany) according to the manufacturer’s protocol (telomeric repeat amplification protocol [TRAP] assay). Heat-treated cellular lysates (85°C for 10 minutes) were used as negative controls for each sample. Samples are considered as telomerase positive if the difference in absorbance is higher than 2-fold background activity. WST-1 assays Cells (0.5 to 5*104) were plated as triplicates in complete RPMI 1640 medium with various concentrations of BIBR1532. After 24 to 72 hours, water-soluble tetrazolium (WST-1) (Roche) was added, which is transformed into formazan by mitochondrial reductase systems. The increase in the number of viable cells results in an increase of activity of mitochondrial dehydrogenases, leading to an increase of formazan dye formed, which was quantified by ELISA reader after 2, 3, and 4 hours of incubation. |
| Concentrations | 0 ~ 80 μM |
| Incubation time | 24 or 72h |
| Animal Experiment | |
|---|---|
| Animal models | Human MM xenograft murine model in CB 17 SCID-mice |
| Formulation | phosphate-buffered saline (PBS) |
| Dosages | 35 mg/kg daily |
| Administration | intraperitoneally |
| Molecular Weight | 331.36 |
| Formula | C21H17NO3 |
| CAS Number | 321674-73-1 |
| Solubility (25°C) | DMSO 70 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Checkpoint Products |
|---|
| PV-1019
PV-1019 (NSC 744039) is a potent, selective Chk2 inhibitor with an IC50 value of 24 nM. PV-1019 inhibits IR-induced apoptosis. |
| CCT241533 dihydrochloride
CCT241533 dihydrochloride is a potent and selective ATP competitive inhibitor of CHK2 with an IC50 of 3 nM and Ki of 1.16 nM. |
| CBP501 Affinity Peptide
CBP501 Affinity Peptide is a Chk kinase inhibitor that can abrogate G2 arrest induced by DNA-damaging agents. |
| Chktide
Chktide is a substrate for CHK1 and CHK2. |
| Zn-DPA-maytansinoid conjugate 1
Zn-DPA-maytansinoid conjugate 1 is a small molecule-based maytansinoid conjugate targeting immune checkpoint. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
